Processing timeline
3
days
Filed
5 Aug 2026
Decision Due
16 Sept 2026
Est decision date: 8 Sept 2026. Based on 59 decided Professional & Business Services notifications.
Acquirer(s)
Danaher Corporation EIN59-1995548
Target(s) or Vendor(s)
SLMP Intermediate Holdings Inc EIN86-1436842
Other parties
None listed
Danaher Corporation proposes to acquire StatLab Medical Products through a Stock Purchase Agreement. Both companies operate in the anatomical pathology sector, supplying equipment, consumables, and workflow solutions. Danaher, via its Leica Biosystems subsidiary, and StatLab both provide core histology instruments and consumables.
Danaher Corporation ( Danaher ) proposes to acquire StatLab Medical Products ( StatLab ) through a Stock Purchase Agreement with SLMP Intermediate Holdings, Inc and StatLab (the Acquisition ). Danaher is a global science and technology company that designs, manufactures and markets professional, medical, industrial and commercial products and services under three core segments: biotechnology, life sciences and diagnostics. Danaher, through its subsidiary Leica Biosystems, supplies anatomical pathology equipment, consumables and workflow solutions, including core histology instruments and consumables. StatLab develops, manufactures, distributes and services pre-analytical and staining consumables and instruments that support the anatomical pathology workflow. StatLab primarily supplies core histology consumables, but also supplies core histology instruments.
The ACCC has prepared a questionnaire on the Acquisition. Submissions or information in response to the questionnaire should be provided by 13 August 2026 via email to mergers@accc.gov.au with the title Submission re: Danaher (Leica Biosystems) – StatLab . The ACCC’s ability to give detailed consideration to submissions received after this time may be limited.